VIRUSES OF THE PARVOVIRIDAE FAMILY: MOLECULAR GENETICAL ASPECTS OF REPRODUCTION AND MEDICAL IMPORTANCE

Cover Page

Cite item

Abstract

Discovery of new parvoviruses led to taxonomical structure and the nomenclature of the Parvoviridae family reevaluation. There are two subfamilies: Densovirinae and Parvovirinae. Densovirinae subfamily consists of viruses of arthropoda. The Parvovirinae subfamily includes eight genuses of vertebrate animals viruses. In this review parvoviruses which are of interest to practical health care will be considered. Data on molecular and biological and virological characteristics of viruses, epidemiological and clinical features of the infections caused by these viruses are submitted. Parvoviruses which
are interesting for human health care belong to five genuses: Bocaparvovirus, Dependoparvovirus, Erythroparvovirus, Protoparvovirus and Tetraparvovirus. The most known person pathogenic parvovirus is the Primate erythroparvovirus 1 virus which was earlier called by Human parvovirus B19. It was discovered in 1975. It relates to the Erythroparvovirus genus. In this review the main attention is paid to less known viruses of this family. In viral lower respiratory tract infections structure the leading place is taken by Human Bocavirus — Primate bocaparvovirus 1 and Primate bocaparvovirus 2 relating to the Bocaparvovirus genus. In 2005, the virus of human, Primate tetraparvovirus 1, was discovered which belongs to the genus Tetraparvovirus. Clinically acute form of a tetraparvoviral infection is a top and lower respiratory tract and an alimentary tract disease. The virus possesses teratogenic action. Protoparvovirus genus representatives cause an alimentary tract disease also. Two species, pathogenic for the person are described. Bufavirus (Primate protoparvovirus 1) was found in 2012. Tuzavirus (Primate protoparvovirus 2, Tusavirus 1) was highlighted in 2014. Rodent protoparvovirus 1 which consist of rodents viruses is very interesting species for therapy of the human. Viruses of this species are capable to infect a wide range of human cancer cells, have the expressed carcinolytic properties and are perspective for treatment of person with a cancer. The human virus of the Dependoparvovirus genus called Human adeno-associated virus was discovered in 1965 in the drugs of an adenovirus. This virus isn’t associated with any disease however the virus can be located in a certain locus of the 19th human chromosome and is a perspective candidate like a vector for the treatment of genetic diseases.

About the authors

A. Yu. Antipova

St. Petersburg Pasteur Institute

Author for correspondence.
Email: anti130403@mail.ru

PhD (Biology), Senior Researcher, Laboratory of Experimental Virology

197101, Russian Federation, St. Petersburg, Mira str., 14, Phone: +7 (812) 232-94-11 (office); +7 (921) 346-07-90 (mobile)

Russian Federation

I. N. Lavrentieva

St. Petersburg Pasteur Institute

Email: fake@neicon.ru

PhD, MD (Medicine), Head of the Laboratory of Experimental Virology

Russian Federation

References

  1. Исаева Е.И., Морозова О.В., Ветрова Е.Н., Вартанян Р.В., Козулина И.С. Детекция, идентификация и количественные оценки бокавируса у детей с острыми респираторными вирусными инфекциями и гастроэнтеритами в Москве // Живые и биокосные системы. 2014. № 9. [Isaeva E.I., Morozova O.V., Vetrova E.N., Vartanyan R.V., Kozulina I.S. Detection, identification and quantitation of bocavirus among children with acute respiratory viral infections and gastroenteritises in Moscow. Zhivye i biokosnye sistemy = Living and Nonliving Systems, 2014, no. 9. URL: http://www.jbks.ru/archive/issue-9/article-18 (02.02.2017). (In Russ.)]
  2. Лаврентьева И.Н., Антипова А.Ю. Парвовирус В19 человека: характеристика возбудителя, распространение и диагностика обусловленной им инфекции // Инфекция и иммунитет. 2013. Т. 3, № 4. C. 311–322. [Lavrentyeva I.N., Antipova A.Y. Human parvovirus B19: virus characteristics, distribution and diagnostics of parvovirus infection. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2013, vol. 3, no. 4, pp. 311–322. doi: 10.15789/2220-7619-2013-4-311-322 (In Russ.)]
  3. Лаврентьева И.Н., Антипова А.Ю., Бичурина М.А., Семенов А.В. Генотипирование изолятов парвовируса В19, циркулирующих в Северо-Западном федеральном округе России // Журнал микробиологии, эпидемиологии и иммунобиологии. 2013. № 6. C. 36–43. [Lavrentieva I.N., Antipova A.Yu., Semenov A.V., Bichurina M.A. Genotuping of Parvovirus B19 isolates circulating in North-Western Federal District of Russia. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology, 2013, no. 6, pp. 36–43. (In Russ.)]
  4. Львов Н.И., Писарева М.М., Мальцев О.В., Бузицкая Ж.В., Афанасьева В.С., Михайлова М.А., Го А., Янина М.А., Резниченко Н.А., Грудинин М.П., Жданов К.В., Лобзин Ю.В. Особенности этиологической структуры ОРВИ в отдельных возрастных и профессиональных группах населения Санкт-Петербурга в эпидемический сезон 2013–2014 гг. // Журнал инфектологии. 2014. Т. 6, № 3. С. 60–70. [Lvov N.I., Pisareva M.M., Maltsev O.V., Buzitskaya J.V., Afanasieva V.S., Mikhailova M.A., Go A., Yanina M.A., Reznichenko N.A., Grudinin M.P., Zhdanov K.V., Lobzin Y.V. The features of ARVD etiological structure in different age and professional population groups in Saint-Petersburg during 2013–2014 epidemic season. Zhurnal infektologii = Journal of Infectology, 2014, vol. 6, no. 3, pp. 62–70. doi: 10.22625/2072-6732-2014-6-3-62-70 (In Russ.)]
  5. Arthur J.L., Higgins G.D., Davidson G.P., Givney R.C., Ratcliff R.M. A novel bocavirus associated with acute gastroenteritis in Australian children. PLoS Pathog., 2009, vol. 5, iss. 4: e1000391. doi: 10.1371/journal.ppat.1000391
  6. Atchison R.W., Casto B.C., Hammon W.M. Adenovirus-associated defective virus particles. Science, 1965, vol. 14, no. 9, pp. 754–756.
  7. Babkin I.V., Tyumentsev A.I., Tikunov A.Y., Zhirakovskaia E.V., Netesov S.V., Tikunova N.V. A study of the human bocavirus replicative genome structures. Virus Res., 2015, vol. 195, pp. 196–202. doi: 10.1016/j.virusres.2014.10.019
  8. Bär S., Rommelaere J., Nüesch J.P. Vesicular transport of progeny parvovirus particles through ER and Golgi regulates maturation and cytolysis. PLoS Pathog., 2013, vol. 9: e1003605. doi: 10.1371/journal.ppat.1003605
  9. Bartlett J.S., Wilcher R., Samulski R.J. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol., 2000, vol. 74, pp. 2777–2785.
  10. Benjamin L.A., Lewthwaite P., Vasanthapuram R., Zhao G., Sharp C., Simmonds P., Wang D., Solomon T. Human parvovirus 4 as potential cause of encephalitis in children, India. Emerg. Infect. Dis., 2011, vol. 17, pp. 1484–1487. doi: 10.3201/eid1708.110165
  11. Canaan S., Zadori Z., Ghomashchi F., Bollinger J., Sadilek M., Moreau M.E., Tijssen P., Gelb M.H. Interfacial enzymology of parvovirus phospholipases A2. J. Biol. Chem., 2004, vol. 279, pp. 14502–14508. doi: 10.1074/jbc.M312630200
  12. Cao M., You H., Hermonat P.L. The X gene of adeno-associated virus 2 (AAV2) is involved in viral DNA replication. PLoS One, 2014, vol. 9, iss. 8: e104596. doi: 10.1371/journal.pone.0104596
  13. Carter B.J. Adeno-associated virus vectors in clinical trials. Human Gene Therapy, 2005, vol. 16, pp. 541–550. doi: 10.1089/hum.2005.16.541
  14. Chandramouli S., Medina-Selby A., Coit D., Schaefer M., Spencer T., Brito L.A., Zhang P., Otten G., Mandl C.W., Mason P.W., Dormitzer P.R., Settembre E.C. Generation of a parvovirus B19 vaccine candidate. Vaccine, 2013, vol. 31, pp. 3872–3878. doi: 10.1016/j.vaccine.2013.06.062
  15. Chen A.Y., Cheng F., Lou S., Luo Y., Liu Z., Zhengwen L., Delwart E., Pintel D., Jianming Q. Characterization of the gene expression profile of human bocavirus. Virology, 2010, vol. 403, no. 2, pp. 145–154. doi: 10.1016/j.virol.2010.04.014
  16. Chen M.Y., Hung C.C., Lee K.L. Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection. Virol. J., 2015, vol. 19, no. 12, pp. 94. doi: 10.1186/s12985-015-0326-0
  17. Chen M.Y., Yang Sh.-J., Hung Ch.-Ch. Placental transmission of Human Parvovirus 4 in newborns with hydrops, Taiwan. Emerg. Infect. Dis., 2011, vol. 17, no. 10, pp. 1954–1956. doi: 10.3201/eid1710.101841
  18. Cheng W., Chen J., Xu Z., Yu J., Huang C., Jin M., Li H., Zhang M., Jin Y., Duan Zh. Phylogenetic and recombination analysis of human bocavirus 2. BMC Infect. Dis., 2011, vol. 11: 50. doi: 10.1186/1471-2334-11-50
  19. Chuang C.Y., Kao Ch.L., Huang L.-M., Lu Ch.-Y., Shao P.-L., Lee P.-I., Chang L.-Y. Human bocavirus as an important cause of respiratory tract infection in Taiwanese children. J. Microbiol., Immunol. Infect., 2011, vol. 44, pp. 323–327. doi: 10.1016/j.jmii.2011.01.036
  20. Corcoran C., Hardie D., Yeats J., Smuts H. Genetic variants of Human Parvovirus B19 in South Africa: cocirculation of three genotypes and identification of a novel subtype of genotype 1. J. Clin. Microbiol., 2010, vol. 48, no. 1, pp. 137–142. doi: 10.1128/JCM.00610-09
  21. Cossart Y.E., Field A.M., Cant B., Widdows D. Parvovius-like particles in human sera. Lancet, 1975, vol. 1, no. 7898, pp. 72–73.
  22. Cotmore S.F., Agbandje-McKenna M., Chiorini J.A., Gatherer D., Mukha D.V., Pintel D.J., Qiu J., Soderlund-Venermo M., Tattersall P., Tijssen P. Rationalization and extension of the taxonomy of the family Parvoviridae. In: ICTV official taxonomy: Updates since the 8th Report, code 2013.001a-aaaV. International Committee on Taxonomy of Viruses (ICTV), 2013. 65 р.
  23. Deng Z.H., Hao Y.X., Yao L.H., Xie Z.P., Gao H.C., Xie L.Y., Zhong L.L., Zhang B., Cao Y.D., Duan Z.J. Immunogenicity of recombinant human bocavirus-1,2 VP2 gene virus-like particles in mice. Immunology, 2014, vol. 142, no. 1, pp. 58–66. doi: 10.1111/imm.12202
  24. Di Pasquale G., Davidson B.L., Stein C.S., Martins I., Scudiero D., Monks A., Chiorini J.A. Identification of PDGFR as a receptor for AAV-5 transduction. Nat. Med., 2003, vol. 9, pp. 1306–1312. doi: 10.1038/nm929
  25. Drexler J.F., Reber U., Muth D., Herzog P., Annan A., Ebach F., Sarpong N., Acquah S., Adlkofer J., Adu-Sarkodie Y., Panning M., Tannich E., May J., Drosten C., Eis-Hübinger A.M. Human parvovirus 4 in nasal and fecal specimens from children, Ghana. Emerg. Infect. Dis., 2012, vol. 18, pp. 1650–1653. doi: 10.3201/eid1810.111373
  26. Endo R., Ishiguro N., Kikuta H., Teramoto S., Shirkoohi R., Ma X., Ebihara T., Ishiko H., Ariga T. Seroepidemiology of human bocavirus in Hokkaido prefecture, Japan. J. Clin. Microbiol., 2007, vol. 45, pp. 3218–3223. doi: 10.1128/JCM.02140-06
  27. Erles K., Rohde V., Thaele M., Roth S., Edler L., Schlehofer J.R. DNA of adeno-associated virus (AAV) in testicular tissue and in abnormal semen samples. Hum. Reprod., 2001, vol. 16, no. 11, pp. 2333–2337.
  28. Fryer J.F., Delwart E., Hecht F.M., Bernardin F., Jones M.S., Shah N., Baylis S.A. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion, 2007, vol. 47, pp. 1054–1061. doi: 10.1111/j.1537-2995.2007.01235.x
  29. Gao G., Vandenberghe L.H., Alvira M.R., Lu Y., Calcedo R., Zhou X., Wilson J.M. Clades of Adeno-associated viruses are widely disseminated in human tissues. J. Virol., 2004, vol. 78, no. 12, pp. 6381–6388. doi: 10.1128/JVI.78.12.6381-6388.2004
  30. Geletneky K., Rommelaere J. Oncolytic parvovirus for cancer of the brain: are we approaching human trials? Future Neurol., 2010, vol. 5, no. 6, pp. 783–785. doi: 10.2217/fnl.10.63
  31. Gonçalves M.A.F.V. Adeno-associated virus: from defective virus to effective vector. Virol. J., 2005, vol. 2: 43. doi: 10.1186/1743-422X-2-43
  32. Grekova S.P., Rommelaere J., Raykov Z. Parvoviruses-tools to fine-tune anticancer immune responses. OncoImmunology, 2012, vol. 1, no. 8, pp. 1417–1419. doi: 10.4161/onci.21097
  33. Grieger J.C., Samulski R.J. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv. Biochem. Eng. Biotechnol., 2005, no. 99, pp. 119–145.
  34. Guido M., Quattrocchi M., Campa A., Zizza A., Grima P., Romano A., De Donno A. Human metapneumovirus and human bocavirus associated with respiratory infection in Apulian population. Virology, 2011, vol. 417, pp. 64–70. doi: 10.1016/j.virol.2011.04.016
  35. Guo L., Wang Y., Zhou H., Wu Ch., Song J., Li J., Paranhos-Baccala G., Vernet G., Wang J., Hung T. Differential seroprevalence of Human Bocavirus species 1-4 in Beijing, China. PLoS ONE, 2012, vol. 7, no. 6, pp. e39644. doi: 10.1371/journal.pone.0039644
  36. Halbert C.L., Allen J.M., Miller A.D. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J. Virol., 2001, vol. 75, no. 14, pp. 6615–6624. doi: 10.1128/JVI.75.14.6615-6624.2001
  37. Hall Auer C., Kronauer G., Siegl G. Parvoviruses as contaminants of permanent human cell lines. Arch. Gesamte Virusforsch., 1971, vol. 35, pp. 80–90. doi: 10.1007/BF01249755
  38. Hamza I.A., Jurzik L., Wilhelm M., Uberla K. Detection and quantification of human bocavirus in river water. J. Gen. Virol., 2009, vol. 90, pp. 2634–2637. doi: 10.1099/vir.0.013557-0
  39. Heegard E.D., Brown K.E. Human parvovirus B19. Clin. Microbiol. Rev., 2002, vol. 15, no. 3, pp. 485–505.
  40. Huang D.-D., Wang W., Lu Q.B., Zhao J., Guo Ch.T., Wang H.Y., Zhang X.A., Tong Y.G., Liu W., Cao W.Ch. Identification of Bufavirus-1 and Bufavirus-3 in feces of patients with acute diarrhea, China. Scientific Reports, 2015, no. 5: 13272. doi: 10.1038/srep13272
  41. Huang Q., Deng X., Yan Z., Cheng F., Luo Y., Shen W., Lei-Butters D.C., Chen A.Y., Li Y., Tang L., Söderlund-Venermo M., Engelhardt J.F., Qiu J. Establishment of a reverse genetics system for studying human bocavirus in human airway epithelia. PLoS Pathog., 2012, vol. 8, iss. 8: e1002899. doi: 10.1371/journal.ppat.1002899
  42. Jacques J., Moret H., Renois F., Leveque N., Motte J., Andreoletti L. Human Bocavirus quantitative DNA detection in French children hospitalized for acute bronchiolitis. J. Clin. Virol., 2008, vol. 43, pp. 142–147. doi: 10.1016/j.jcv.2008.05.010
  43. Jones M.S., Kapoor A., Lukashov V.V., Simmonds P., Hecht F., Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J. Virol., 2005, vol. 79, pp. 8230–8236. doi: 10.1128/JVI.79.13.8230-8236.200
  44. Kapoor A., Simmonds P., Slikas B., Li L., Bodhidatta L., Sethabutr O., Triki H., Bahri O., Oderinde B.S., Baba M., Bukbuk D.N., Besser J., Bartkus J., Delwart E. Human bocaviruses are highly diverse, dispersed, recombination prone, and prevalent in enteric infections. J. Infect. Dis., 2010, vol. 201, no. 11, pp. 1633–1643. doi: 10.1086/652416.
  45. Kashiwakura Y., Tamayose K., Iwabuchi K., Hirai Y., Shimada T., Matsumoto K., Nakamura T., Oshimi K., Daida H. Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. J. Virol., 2005, vol. 79, pp. 609–614. doi: 10.1128/JVI.79.1.609-614.2005
  46. Koks C.A.E., De Vleeschouwer S., Graf N., Van Gool1 S.W.N. Immune suppression during oncolytic virotherapy for high-grade glioma: yes or no? J. Cancer, 2015, vol. 6, pp. 203–217. doi: 10.7150/jca.10640
  47. Lou S., Xu B., Huang Q., Zhi N., Cheng F., Wong S., Brown K., Delwart E., Liu Zh., Qiu J. Molecular characterization of the newly identified human parvovirus 4 in the family Parvoviridae. Virology, 2012, vol. 422, no. 1, pp. 59–69. doi: 10.1016/j.virol.2011.09.033
  48. Manning A., Willey S.J., Bell J.E., Simmonds P. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J. Infect. Dis., 2007, vol. 195, no. 9, pp. 1345–1352. doi: 10.1086/513280
  49. Manno C.S., Chew A.J., Hutchison S., Larson P.J., Herzog R.W., Arruda V.R., Tai S.J., Ragni M.V., Thompson A., Ozelo M., Couto L.B., Leonard D.G., Johnson F.A., McClelland A., Scallan C., Skarsgard E., Flake A.W., Kay M.A., High K.A., Glader B. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood, 2003, vol. 101, no. 8, pp. 2963–2972. doi: 10.1182/blood-2002-10-3296
  50. Marchini A., Bonifati S., Scott E.M., Angelova A.L., Rommelaere J. Oncolytic parvoviruses: from basic virology to clinical applications. Virol. J., 2015, vol. 12: 16. doi: 10.1186/s12985-014-0223-y
  51. Matthews Ph.C., Malik A., Simmons R., Sharp C., Simmonds P., Klenerman P. PARV4: an emerging tetraparvovirus. PLOS Pathog., 2014, vol. 10, no. 5: e1004036. doi: 10.1371/journal.ppat.1004036
  52. Meriluoto M., Hedman L., Tanner L., Simell V., Mäkinen M., Simell S., Mykkänen J., Korpelainen J., Ruuskanen O., Ilonen J., Knip M., Simell O., Hedman K., Söderlund-Venermo M. Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland. Emerg. Infect. Dis., 2012, vol. 18, pp. 264–271. doi: 10.3201/eid1802.111293
  53. Meyers C., Mane M., Kokorina N., Alam S., Hermonatt P.L. Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model. Virology, 2000, vol. 272, pp. 338–346. doi: 10.1006/viro.2000.0385
  54. Mitui M.T., Shahnawaz Bin Tabib S.M., Matsumoto T., Khanam W., Ahmed S., Mori D., Akhter N., Yamada K., Kabir L., Nishizono A., Söderlund-Venermo M., Ahmed K. Detection of human bocavirus in the cerebrospinal fluid of children with encephalitis. Clin. Infect. Dis., 2012, vol. 54, no. 7, pp. 964–967. doi: 10.1093/cid/cir957
  55. Mori D., Ranawaka U., Yamada K., Rajindrajith Sh., Miya K., Perera H.K.K., Matsumoto T., Dassanayake M., Mitui M.T., Mori H., Nishizono A., Söderlund-Venermo M., Ahmed K. Human bocavirus in patients with encephalitis Sri Lanka, 2009–2010. Emerg. Infect. Dis., 2013, vol. 19, no. 11, pp. 1859–1862. doi: 10.3201/eid1911.121548
  56. Mueller Ch., Chulay J.D., Trapnell B.C., Humphries M., Carey B., Sandhaus R.A., McElvaney N.G., Messina L., Tang Q., Rouhani F.N., Campbell-Thompson M., Fu A.D., Yachnis A., Knop D.R., Ye G., Brantly M., Calcedo R., Somanathan S., Richman L.P., Vonderheide R.H., Hulme M.A., Brusko T.M., Wilson J.M., Flotte T.R. Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression. J. Clin. Invest., 2013, vol. 123, pp. 5310–5318. doi: 10.1172/JCI70314
  57. Nüesch J.P.F., Lacroix J., Marchini A., Rommelaere J. Molecular pathways: rodent parvoviruses — mechanisms of oncolysis and prospects for clinical cancer treatment. Clin. Cancer Res., 2012, vol. 18, no. 13, pp. 3516–3523. doi: 10.1158/1078-0432.CCR-11-2325
  58. Oliveira E.M., Phillips M.I. Associated adeno virus vector for producing induced pluripotent stem cells (IPS) for human somatic cells. In: Stem cells in clinic and research. Ed. A. Gholamrezanezhad. InTech, 2011, pp. 747–764. doi: 10.5772/22823
  59. Paglino J.C., Ozduman K., Van den Pol A.N. LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells. J. Virol., 2012, vol. 86, no. 13, pp. 7280–7291. doi: 10.1128/JVI.00227-12
  60. Panning M., Kobbe R., Vollbach S., Drexler J.F., Adjei S., Adjei O., Drosten Ch., May J., Eis-Hübinger A.M. Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg. Infect. Dis., 2010, vol. 16, pp. 1143–1146. doi: 10.3201/eid1607.100025
  61. Phan T.G., Sdiri-Loulizi K., Aouni M., Ambert-Balay K., Pothier P., Deng X., Delwart E. New parvovirus in child with unexplained diarrhea, Tunisia. Emerg. Infect. Dis., 2014, vol. 20, no. 11, pp. 1911–1913. doi: 10.3201/eid2011.140428
  62. Phan T.G., Vo N.P., Bonkoungou I.J., Kapoor A., Barro N., O’Ryan M., Kapusinszky B., Wang Ch., Delwarta E. Acute diarrhea in West African children: diverse enteric viruses and a novel parvovirus genus. J. Virol., 2012, vol. 86, no. 20, pp. 11024–11030. doi: 10.1128/JVI.01427-12
  63. Tg Rogayah T.A.R., Fauziah M.K., Apandi Y.M., Zarina M.Z., Nur Izmawati A.R., Nur Azrenawaty M.N., Tg Aman Arif T.M.A.S., Zainah S. Molecular epidemiology of human bocavirus in children with acute respiratory infections in Malaysia. Innov. J. Med. Health Sci., 2014, vol. 4, pp. 319–323.
  64. Schildgen O., Müller A., Allander T., Mackay I.M., Völz S., Kupfer B., Simon A. Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin. Microbiol. Rev., 2008, vol. 21, no. 2, pp. 291–304. doi: 10.1128/CMR.00030-07
  65. Schmidt M., Voutetakis A., Afione S., Zheng C., Mandikian D., Chiorini J.A. Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity. J. Virol., 2008, vol. 82, pp. 1399–1406. doi: 10.1128/JVI.02012-07
  66. Sharp C.P., Lail A., Donfield S., Gomperts E.D., Simmonds P. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates. Transfusion, 2012, vol. 52, pp. 1482–1489. doi: 10.1111/j.1537-2995.2011.03420.x
  67. Sharp C., Vermeulen M., Nébié Y., Djoko C.F., LeBreton M., Tamoufe U., Rimoin A.W., Kayembe P.K., Carr J.K., Servant-Delmas A., Laperche S., Harrison G.L., Pybus O.G., Delwart E., Wolfe N.D., Saville A., Lefrère J.J., Simmonds P. Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa. Emerg. Infect. Dis., 2010, vol. 16, pp. 1605–1607. doi: 10.3201/eid1610.101001
  68. Shirkoohi R., Endo R., Ishiguro N., Teramoto Sh., Kikuta H., Ariga T. Antibodies against structural and nonstructural proteins of human bocavirus in human sera. Clin. Vaccine Immunol., 2010, vol. 17, no. 1, pp. 190–193. doi: 10.1128/CVI.00355-09
  69. Simmons R., Sharp C., Levine J., Bowness P., Simmonds P., Cox A., Klenerman P. Evolution of CD8+ T cell responses after acute PARV4 infection. J. Virol., 2013, vol. 87, pp. 3087–3096. doi: 10.1128/JVI.02793-12
  70. Smuts H., Kew M., Khan A., Korsman S. Novel hybrid parvovirus-like virus, NIH-CQV/PHV, contaminants in silica columnbased nucleic acid extraction kits. J. Virol., 2014, vol. 88, no. 2, pp. 1398. doi: 10.1128/JVI.03206-13
  71. Song J., Jin Y., Xie Zh., Gao H., Xiao N., Chen W., Xu Z., Yan K., Zhao Y., Hou Y., Duan Zh. Novel human bocavirus in children with acute respiratory tract infection. Emerg. Infect. Dis., 2010, vol. 16, no. 2, pp. 324–327. doi: 10.3201/eid1602.090553
  72. Streiter M., Malecki M., Prokop A., Schildgen V., Lüsebrink J., Guggemos A., Wibkirchen M., Weib M., Cremer R., Brockmann M., Schildgen O. Does human bocavirus infection depend on helper viruses. A challenging case report. Virol. J., 2011, vol. 8: 417. doi: 10.1186/1743-422X-8-417
  73. Sun B., Cai Y., Li Y., Li J., Liu K., Li Y., Yang Y. The nonstructural protein NP1 of human bocavirus 1 induces cell cycle arrest and apoptosis in Hela cells. Virology, 2013, vol. 440, pp. 75–83. doi: 10.1016/j.virol.2013.02.013
  74. Tamošiūnas P.L., Simutis K., Kodzė I., Firantienė R., Ėmužytė R., Petraitytė-Burneikienė R., Žvirblienė A., Sasnauskas K. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virusspecific antibodies in human serum. Intervirology, 2013, vol. 56, no. 5, pp. 271–277. doi: 10.1159/000353112
  75. Tu M., Liu F., Chen Sh., Wang M., Cheng A. Role of capsid proteins in parvoviruses infection. Virol. J., 2015, vol. 12: 114. doi: 10.1186/s12985-015-0344-y
  76. Tuke Ph.W., Parry R.P., Appleton H. Parvovirus PARV4 visualization and detection. J. Gen. Virol., 2010, vol. 91, pp. 541–544. doi: 10.1099/vir.0.014852-0
  77. Väisänen E., Kuisma I., Phan T.G., Delwart E., Lappalainen M., Tarkka E., Hedman K., Söderlund-Venermo M. Bufavirus in feces of patients with gastroenteritis, Finland. Emerg. Infect. Dis., 2014, vol. 20, no. 6, pp. 1077–1079. doi: 10.3201/eid2006.131596
  78. Vollmers E.M., D’Abramo A.Jr., Cotmore S.F., Tattersall P. Genome sequence of Tumor Virus X, a member of the genus Protoparvovirus in the family Parvoviridae. Genome Announc., 2014, vol. 2, no. 4: e00758-14. doi: 10.1128/genomeA.00758-14
  79. Vollmers E.M., Tattersall P. Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses. Virology, 2013, vol. 446, pp. 37–48.
  80. Walz C.M., Anisi T.R., Schlehofer J.R., Gissmann L., Schneider A., Muller M. Detection of infectious adeno-associated virus particles in human cervical biopsies. Virology, 1998, vol. 247, no. 97–105.
  81. Wang Z., Ma H.I., Li J., Sun L., Zhang J., Xiao X. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther., 2003, vol. 10, no. 26, pp. 2105–2111. doi: 10.1038/sj.gt.3302133
  82. Ward P., Walsh Ch.E. Targeted integration of a rAAV vector into the AAVS1 region. Virology, 2012, vol. 433, pp. 356–366.
  83. Xu Z., Cheng W., Li B., Li J., Lan B., Duan Zh. Development of a real-time PCR assay for detecting and quantifying Human bocavirus 2. J. Clin. Microbiol., 2011, vol. 49, no. 4, pp. 1537–1541. doi: 10.1128/JCM.00196-10
  84. Yahiro T., Wangchuk S., Tshering K., Bandhari P., Zangmo S., Dorji T., Tshering K., Matsumoto T., Nishizono A., Söderlund- Venermo M., Ahmed K. Novel human bufavirus genotype 3 in children with severe diarrhea, Bhutan. Emerg. Infect. Dis., 2014, vol. 20, no. 6, pp. 1037–1039. doi: 10.3201/eid2006.131430
  85. Young S.M. Jr, McCarty D.M., Degtyareva N., Samulski R.J. Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination. J. Virol., 2000, vol. 74, pp. 3953–3966.
  86. Yu X., Wang J., Zhao B., Ghildyal R. PARV4 co-infection is associated with disease progression in HBV patients in Shanghai. J. Med. Diagn. Meth., 2015, vol. 4, pp. 168. doi: 10.4172/2168-9784.1000168
  87. Zhang Z., Zheng Z., Luo H., Meng J., Li H., Li Q., Zhang X., Ke X., Bai B., Mao P., Hu Q., Wang H. Human Bocavirus NP1 Inhibits IFN-b production by blocking association of IFN regulatory factor 3 with IFNB promoter. J. Immunol., 2012, vol. 189, pp. 1–10. doi: 10.4049/jimmunol.1200096
  88. Zhou Zh., Gao X., Wang Y., Zhou H., Wu Ch., Paranhos-Baccalà G. Conserved B-cell epitopes among Human bocavirus species indicate potential diagnostic targets. PLoS One, 2014, vol. 9, no. 1: e86960. doi: 10.1371/journal.pone.0086960

Copyright (c) 2017 Antipova A.Y., Lavrentieva I.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies